Galanin receptor galr2
CA 2256523 A1 · Owner: Mccaleb, Michael L. · Inventors: Mccaleb, Michael L.; Bloomquist, Brian T.; Heeja, Yoo-Warren
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a novel galanin receptor protein the GalR2 , receptor. Also provided are the nucleic acid sequences encoding this novel receptor protein as well as methods for using this protein and its nucleic acid sequence, and methods useful for developing and identifying compounds for the treatment of diseases and disorders in which galanin is implicated. The importance of this discovery is manifested in the effects of galanin which , include antinociceptive activity smooth muscle contraction, cardiovascular activity, pituitary hormone release, cognition and increased food intake. , Thus, this receptor protein is useful for screening for galanin agonist and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 5, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.